comparemela.com

Latest Breaking News On - Jay luly - Page 1 : comparemela.com

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

China
Matthew-kowalsky
Scott-rottinghaus
Akash-tewari
Jennifer-viera
Deric-joseph
Tara-kieffer
Paul-mellett
Ed-arce
Enanta-pharmaceuticals-inc
Nasdaq
Pfizer

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript February 7, 2024 Enanta Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to Enanta Pharmaceuticals’ Fiscal First Quarter Financial Results Conference Call. At this time, […]

Paul-mellett
Pfizer
Speaking-countries
Quality-makeup-brands-in-the
Chronic-obstructive-pulmonary-disease
Paul-mellett
Chronic-spontaneous-urticaria
Jennifer-viera
Jay-luly
Chief-executive-officer
Clinical-development

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Fourth Quarter and Year-End Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Canada
Jay-olson
Scott-rottinghaus
Tara-kieffer
Jennifer-viera
Roanna-ruiz
Paul-mellett
Nasdaq
Enanta-pharmaceuticals-inc
Enanta-pharmaceuticals-fiscal-fourth-quarter
Pfizer
Enanta-pharmaceuticals

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q3 2023 Earnings Call Transcript

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q3 2023 Earnings Call Transcript August 7, 2023 Enanta Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.86 EPS, expectations were $2.38. Operator: Good afternoon, and welcome to Enanta Pharmaceuticals’ Fiscal Third Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode. There will […]

Canada
California
United-states
Paul-mellett
Pressmaster-shutterstock
Southern-hemispheres
Northern-hemisphere
Enanta-pharmaceuticals
Nc
Enanta-pharmaceuticals
Paul-mellett

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Enanta Pharmaceuticals’ Fiscal Third Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode.

Canada
California
United-states
Paul-mellett
Scott-rottinghaus
Pressmaster-shutterstock
Tara-kieffer
Brian-abrahams
Jennifer-viera
Enanta-pharmaceuticals-inc
Nasdaq
Enanta-pharmaceuticals

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.